en · de · es · pt
thymosin-alpha-1-notes.peptides3626.com › Blog › Molecular Identity Of Thymosin Alpha-1 — Deep Dive

Molecular Identity Of Thymosin Alpha-1 — Deep Dive

By Editorial Desk · published 2025-07-29 · last reviewed 2025-09-06 · Blog

This is a working overview of prothymosin alpha, written for readers who want more than a one-paragraph summary but less than a textbook.

Reviewed 2025-09-06. Anything still debated is marked as such rather than presented as settled.

Molecular Identity Of Thymosin Alpha-1

Most published studies on thymosin alpha-1 report changes in immune measurements rather than clinical outcomes, and findings differ across designs and populations. Whether the peptide signals through one defined receptor or through several less specific interactions remains an open question. Its reported circulation half-life of a few hours complicates comparison of dosing schedules across trials. Mechanistic claims are frequently drawn from isolated cell cultures, and how far those results extend to whole organisms is unresolved.

Thymosin alpha-1 is a synthetic peptide of 28 amino acids whose sequence matches the amino-terminal region of prothymosin alpha. The chain is acetylated at its first residue and contains one disulfide bridge between two cysteine residues, which folds the molecule into a compact loop. Its molecular formula, C129H215N33O55, corresponds to a monoisotopic mass of roughly 3,106 daltons. Material used in laboratories is made by solid-phase synthesis rather than isolated from animal tissue.

Early work on thymic extracts in the 1960s described a heat-stable acidic fraction containing many polypeptides. Separation of that mixture yielded individual components, and thymosin alpha-1 was named as one of them on the basis of assays for T-cell activity. The first preparations came from calf thymus, while subsequent research and clinical material has been chemically synthesized. Nomenclature in older papers is inconsistent, and the same peptide sometimes appears under different designations, which complicates literature searches.

Storage Stability and Analytical Testing

Identity and purity are normally assessed by reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities and truncation products. Mass spectrometry confirms molecular mass and detects modifications such as deamidation or oxidation. Amino acid analysis and peptide mapping provide additional sequence-level confirmation. For research material, a certificate of analysis typically reports these results together with water content and counter-ion identity, since the lyophilized powder is often supplied as an acetate or trifluoroacetate salt.

Several factors accelerate degradation: alkaline pH, elevated temperature, exposure to oxidants, and the presence of residual moisture. Deamidation of asparagine residues and oxidation of methionine are the most commonly reported degradation routes. Because the peptide lacks disulfide bonds, it does not undergo the thiol-related aggregation seen in some other biologics, but physical aggregation can still occur at high concentration. Stability data are product-specific, and extrapolating shelf life between formulations is not reliable.

Thymosin-alpha-1 at a glance

PropertyValueNotes
ClassSynthetic peptide28 residues; not a small-molecule compound
Molecular massAbout 3,106 DaMonoisotopic mass of the unmodified chain
N-terminal groupAcetylated serinePresent in both native and synthetic forms
Secondary structureDisulfide-constrained loopOne bridge between two cysteine residues
Typical sourceSolid-phase synthesisEarly isolates came from bovine thymus extracts

Molecular Structure and Biological Background

The peptide was described in the 1970s as a component of thymic extracts, and early research focused on restoring immune function in immunodeficiency states. A synthetic version entered clinical development in the 1980s and is approved as a drug in several countries for conditions such as chronic hepatitis B and certain immunodeficiencies. Approval status varies widely by jurisdiction, and in the United States it is not an approved therapeutic. Regulatory and clinical positions differ, so statements about efficacy should be tied to specific indications and studies.

Thymosin alpha-1 is a synthetic peptide of 28 amino acids, corresponding to the N-terminal fragment of prothymosin alpha. Its sequence begins with acetylation at the N-terminus, a modification that affects stability and receptor interaction. The peptide is acidic, with a calculated isoelectric point near 4.2, and carries no disulfide bonds, so its secondary structure is largely flexible in solution. Molecular mass is approximately 3108 daltons. The native form was first isolated from bovine thymus tissue, while pharmaceutical material is produced by solid-phase peptide synthesis.

Related pages on this site

Handling, Storage, and Analytical Methods

The peptide lacks cysteine, methionine, and tryptophan, so disulfide scrambling and sulfur oxidation are not major degradation routes. Instead, aspartate residues can undergo isomerization or cyclization to succinimide intermediates, generating isoaspartate variants. Hydrolysis of peptide bonds also occurs slowly in solution. These changes may reduce biological activity even when the main peak remains detectable. Stability studies therefore track both potency and the appearance of related substances.

Lyophilized thymosin alpha 1 is typically stored refrigerated at 2 to 8 degrees Celsius and kept away from light. Reconstituted solutions are less stable and are usually used promptly after preparation. Repeated freeze-thaw cycles are avoided because they can promote aggregation and loss of activity. The peptide adsorbs to some plastic and glass surfaces, so a carrier protein is often added to dilute working solutions. Manufacturer instructions and published protocols both govern handling.

Supporting material

isoform.io is a database of AlphaFold2-generated structures of proposed splice isoforms in the human genome. It includes information from 237,275 human transcripts. It has been used to detect errors in the mRNA predictions for a handful of genes. AlphaFold has shown certain limitations. AlphaFold DB provides models of individual protein chains (monomers), rather than their biologically relevant complexes. Many protein regions are predicted with low confidence score, including the intrinsically disordered protein regions. Alphafold-2 was validated for predicting effects of point mutations on structure and free energy, with a partial success.

It is a cyclin dependent kinase containing the catalytic subunit, Cdk9, and a regulatory subunit, cyclin T in Drosophila. In humans there are multiple forms of P-TEFb which contain Cdk9 and one of several cyclin subunits, cyclin T1, T2, and K. P-TEFb associates with other factors including the bromodomain protein BRD4, and is found associated with a large complex of proteins called the super elongation complex. Importantly, for the AIDS virus, HIV, P-TEFb is targeted by the HIV Tat protein which bypasses normal cellular P-TEFb control and directly brings P-TEFb to the promoter proximal paused polymerase in the HIV genome.

Fast breeder reactors (FBRs) which use 'fast' (i.e. unmoderated) neutrons to breed fissile plutonium (and possibly higher transuranics) from fertile uranium-238. The fast spectrum is flexible enough that it can also breed fissile uranium-233 from thorium, if desired. Thermal breeder reactors which use 'thermal-spectrum' or 'slow' (i.e. moderated) neutrons to breed fissile uranium-233 from thorium. Due to the behavior of the various nuclear fuels, a thermal breeder is thought commercially feasible only with thorium fuel, which avoids the buildup of the heavier transuranics.

== Early years == This hypothesis was first proposed by Jaak Panksepp in a 1979 paper, in which he speculated that autism might be "an emotional disturbance arising from an upset in the opiate systems in the brain". Kalle Reichelt then emerged as one of the leading advocates of this theory, publishing papers alleging that "the patterns of peptides and associated proteins from urinary samples [from people with autism] differ considerably from each other and from normal controls." In addition, Reichelt's research has concluded that autistic individuals have increased levels of these peptides in their cerebrospinal fluid. Additionally, in a 1991 paper, Reichelt argued that gluten and casein may play a causative role in autism, as the incomplete digestion thereof may produce certain opioid peptides. Thus, those, such as Paul Shattock, who advocate this theory also advocate the use of a gluten-free, casein-free diet as a treatment for autism.

Sources: en.wikipedia.org

Supporting material

== A New Efficient Synthesis and Usage == Scientists Miquel Vila-Perello´, Matthew R. Pratt, Frej Tulin, and Tom W. Muir wanted to create an efficient synthesis as the original had required an enzymatic solution and had a low yield. So, they started with L-glutamic acid with protecting groups on both the carboxylic acid (tert-butyl), and Boc on the amine. This synthesis will not undergo detail as the classic, but below is the full synthesis. To find the actual steps, look to the reference.

a period set by the employer and no longer than 60 days has lapsed since the employee has reported the incident to her/his employer, and the employer has not addressed the irregularity, or it is obvious that the employer has insufficiently addressed the irregularity. Article 321aquarter provides that an employee may exceptionally directly report to an authority. Exceptions apply in cases.

== Lead-210 == Lead-210 (210Pb) is a radiogenic isotope of lead, found in the decay chain of uranium-238. It is a beta emitter with a half-life of 22.20 years. In addition to dating recent sediments, 210Pb is widely applied for studying soil erosion and sedimentation dynamics in agricultural and natural environments. The unsupported or excess component (210Pbex), derived from atmospheric fallout of radon-222 decay products, accumulates in surface soils and decays with a half-life of 22.3 years. Its depth-dependent activity profile enables reconstruction of soil redistribution over the past century. Because 210Pb deposition is continuous and globally widespread, the method provides a long-term perspective that complements the medium-term records obtained from anthropogenic radionuclides such as 137Cs. It has been used to quantify erosion and deposition rates, assess land degradation, and evaluate soil conservation practices, offering valuable data for geomorphic and environmental research. The radiation emitted by lead-210 can cause issues for some particle physics experiments which has resulted in the use of ancient Roman lead in such applications where the lead-210 has had time to decay to far lower levels.

At the height of the pandemic in mid-2021, the Philippines was a COVID-19 hotspot in Asia; vaccine hesitancy was a problem, and many citizens opted to wait for Western vaccines to arrive. In exasperation, Duterte urged the public to undergo vaccination, threatening to arrest unvaccinated individuals and order local leaders to compile a list of defiant residents. In May 2021, to encourage the public that vaccines were safe, Duterte—acting on the advice of his doctor—publicly took the Sinopharm BIBP vaccine before it was approved for use by the Philippine Food and Drug Administration; his move, however, drew criticism since the general public had access to CoronaVac vaccines, which the public majority perceived to have lower efficacy. The backlash prompted Duterte to apologize, acknowledge the possibility of the Sinopharm vaccine's multiple side effects, and decide to pull out the vaccines. The public's prejudice against China's CoronaVac was later revealed in a Reuters 2024 report as the outcome of a US government-launched covert propaganda and disinformation campaign that aimed to erode the public's trust in China-developed vaccines. Duterte gradually relaxed quarantine restrictions to revive the economy. Upon leaving office, Duterte's administration secured 245 million vaccine doses; about 70.5 million individuals had been fully vaccinated. Over 3.7 million COVID-19 cases were recorded since the onset of the pandemic, 3.69 million people had recovered from the disease, while 8,706 active cases remained.

== Background == According to Paton, the song is inspired by the sunrise on Blackford Hill in Edinburgh. In a 2012 interview with Hotdisc Television, Paton also stated that at the time, his wife said she had "never seen a daybreak", which also inspired the song.

Sources: en.wikipedia.org

Frequently asked questions

Is this peptide found naturally in the body?

Its sequence corresponds to the amino-terminal portion of prothymosin alpha, a larger protein present in many cell types. The isolated 28-residue peptide is a fragment of that protein rather than a separately encoded molecule, and laboratory material is produced by synthesis.

Why is the disulfide bridge important?

The single bridge between two cysteine residues holds the chain in a folded loop that influences its shape and its behavior in solution. Loss of the bridge through reduction or oxidation shifts chromatographic retention and is tracked during stability work.

How does it differ from other thymic peptides?

It is a defined 28-residue sequence derived from a larger precursor, whereas many other thymic preparations are mixtures of several polypeptides. Its acetylated amino terminus and single disulfide bridge distinguish it chemically from unrelated thymic extracts.

Can the powder be stored at room temperature?

Dry lyophilized powder tolerates short ambient exposure during handling and shipping. Long-term room-temperature storage is not recommended because moisture uptake and slow degradation can occur over months. Storage at minus twenty degrees Celsius is the common practice for extended periods.

Network